--- title: "Scienture Holdings (SCNX) stock: news and investor profile" url: "https://aibio.space/companies/scienture/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Scienture Holdings, Inc. (NASDAQ: SCNX), United States. Listing facts, related biotech companies and news on aibio.space." --- SCNX Scienture Holdings, Inc. NASDAQ · United States # Scienture Holdings (SCNX) news Company Updates · 2026-10-13 ## [Scienture expects preliminary third-quarter revenue of about $1.22 million](https://aibio.space/news/scienture-expects-preliminary-third-quarter-revenue-about-1-22-million/) Preliminary revenue rose 256% from the second quarter after the REZENOPY launch and higher Arbli wholesale unit sales. The figures are unaudited. ## Latest Scienture Holdings news 1. 2026-08-14 Company Updates [Scienture reports second quarter 2026 revenue of $343,639](https://aibio.space/news/scienture-reports-second-quarter-2026-revenue-343-639/) Revenue rose from $56,325 in the first quarter, gross margin was approximately 97.7% and the net loss narrowed to about $2.8 million. The company began commercial launch of REZENOPY during the quarter. 2. 2026-05-26 Company Updates [Scienture CFO resigns and Narasimhan Mani named interim CFO](https://aibio.space/news/scienture-cfo-resigns-narasimhan-mani-named-interim-cfo/) Eric Sherb resigned as chief financial officer on May 26, 2026. Dr. Narasimhan Mani, already a director and Co-Chief Executive Officer, took the interim role the same day. 3. 2026-05-18 Company Updates [Scienture reports Q1 2026 revenue of $56 thousand and a 95.6% gross margin](https://aibio.space/news/scienture-reports-q1-2026-revenue-56-thousand-95-6-percent-gross/) Revenue rose 449% from a year earlier on more Arbli orders. The company also reported $11.0 million of non-dilutive debt financing. 4. 2026-04-27 Debt Financing [Scienture closes $8 million note purchase with Streeterville Capital](https://aibio.space/news/scienture-closes-8-million-note-purchase-streeterville-capital/) The April 27, 2026 agreement issued an A-1 note and a B note to Streeterville Capital, LLC. Maxim Group LLC served as placement agent. ## Scienture Holdings at a glance - **Ticker**: SCNX - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $8.2 million ### Related companies - [Aclarion](https://aibio.space/companies/aclarion/) NASDAQ: ACON - [AVITA Medical](https://aibio.space/companies/avita-medical/) NASDAQ: RCEL - [REVVITY, INC.](https://aibio.space/companies/revvity/) NYSE: RVTY - [Innovative Eyewear](https://aibio.space/companies/innovative-eyewear/) NASDAQ: LUCY - [Tenon Medical](https://aibio.space/companies/tenon-medical/) NASDAQ: TNON - [Twist Bioscience](https://aibio.space/companies/twist-bioscience/) NASDAQ: TWST - [Lucid Diagnostics](https://aibio.space/companies/lucid-diagnostics/) NASDAQ: LUCD - [Modular Medical](https://aibio.space/companies/modular-medical/) NASDAQ: MODD ### Also on NASDAQ - [Biomea Fusion](https://aibio.space/companies/biomea-fusion/) BMEA - [Embecta](https://aibio.space/companies/embecta/) EMBC - [Mirum Pharmaceuticals](https://aibio.space/companies/mirum-pharmaceuticals/) MIRM - [MindWalk Holdings](https://aibio.space/companies/mindwalk/) HYFT - [CDT Equity](https://aibio.space/companies/cdt-equity/) CDT - [Atara Biotherapeutics](https://aibio.space/companies/atara-biotherapeutics/) ATRA ## Scienture Holdings annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$2.0 million](https://www.sec.gov/Archives/edgar/data/1382574/000149315226013475/) | [$2.2 million](https://www.sec.gov/Archives/edgar/data/1382574/000149315226013475/) | | Net income (loss) | [-$41.5 million](https://www.sec.gov/Archives/edgar/data/1382574/000149315226013475/) | [$9.1 million](https://www.sec.gov/Archives/edgar/data/1382574/000149315226013475/) | | Cash from operations | [-$13.4 million](https://www.sec.gov/Archives/edgar/data/1382574/000149315226013475/) | [-$14.3 million](https://www.sec.gov/Archives/edgar/data/1382574/000149315226013475/) | | Cash and equivalents | [$6.7 million](https://www.sec.gov/Archives/edgar/data/1382574/000149315226037754/) | [$308,096](https://www.sec.gov/Archives/edgar/data/1382574/000149315226037754/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $8.2 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Scienture Holdings What is the ticker symbol of Scienture Holdings? Scienture Holdings, Inc. trades under the ticker SCNX on NASDAQ. Where is Scienture Holdings listed? Scienture Holdings, Inc. is listed on NASDAQ. Which country or territory is Scienture Holdings listed under? Our directory records Scienture Holdings, Inc. under United States. Does aibio.space cover Scienture Holdings? aibio.space lists Scienture Holdings, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Is Scienture Holdings profitable? Scienture Holdings, Inc. reported a net loss of $41.5 million for the fiscal year ended Dec 31, 2025, and used $13.4 million of cash in operations, per its annual report to the SEC. How much does Scienture Holdings spend on research and development? $2.0 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Scienture Holdings have? $8.2 million in cash at Jun 30, 2026, per its 10-Q. What is the latest Scienture Holdings (SCNX) stock news? Our latest story on Scienture Holdings, dated Oct 13, 2026: "Scienture expects preliminary third-quarter revenue of about $1.22 million". Preliminary revenue rose 256% from the second quarter after the REZENOPY launch and higher Arbli wholesale unit sales. The figures are unaudited. [Source](https://aibio.space/news/scienture-expects-preliminary-third-quarter-revenue-about-1-22-million/). Does Scienture Holdings have debt, a term loan or convertible notes? Our latest debt story, dated Apr 27, 2026: "Scienture closes $8 million note purchase with Streeterville Capital". The April 27, 2026 agreement issued an A-1 note and a B note to Streeterville Capital, LLC. Maxim Group LLC served as placement agent. [Source](https://aibio.space/news/scienture-closes-8-million-note-purchase-streeterville-capital/). How can I follow Scienture Holdings (SCNX) news? Press Follow on this page to add Scienture Holdings to your Following list, or subscribe to the aibio.space newsletter. We have published 5 stories naming Scienture Holdings so far, in Company Updates, Debt Financing. ## Investor discussion: Scienture Holdings Members talk about Scienture Holdings (SCNX). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Scienture Holdings, newest first. Each line links the filing it comes from. 1. 2026-10-19 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 2.02,3.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1382574/000149315226047579/ex99-1.htm) 2. 2026-10-07 Listings Reported a reverse stock split. SEC Form 8-K (Items 3.03,5.03,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1382574/000149315226046176/ex99-1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:SCNX on TradingView](https://www.tradingview.com/symbols/NASDAQ-SCNX/). ## Listing details Scienture Holdings, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker SCNX, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Scienture Holdings, Inc. - **Ticker**: SCNX - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/scienture/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Scienture Holdings (SCNX) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/scienture/